Clinical Trials Browser

Phase NA × irinotecan sucrosofate × Thoracic × Clear all

NCT06258642 2025-08-20

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

Phase NA Recruiting

Small Cell Lung Carcinoma